The genetics of addiction-a translational perspective
- PMID: 22806211
- PMCID: PMC3410620
- DOI: 10.1038/tp.2012.54
The genetics of addiction-a translational perspective
Erratum in
- Transl Psychiatry. 2012;2:e193
Abstract
Addictions are serious and common psychiatric disorders, and are among the leading contributors to preventable death. This selective review outlines and highlights the need for a multi-method translational approach to genetic studies of these important conditions, including both licit (alcohol, nicotine) and illicit (cannabis, cocaine, opiates) drug addictions and the behavioral addiction of disordered gambling. First, we review existing knowledge from twin studies that indicates both the substantial heritability of substance-specific addictions and the genetic overlap across addiction to different substances. Next, we discuss the limited number of candidate genes which have shown consistent replication, and the implications of emerging genomewide association findings for the genetic architecture of addictions. Finally, we review the utility of extensions to existing methods such as novel phenotyping, including the use of endophenotypes, biomarkers and neuroimaging outcomes; emerging methods for identifying alternative sources of genetic variation and accompanying statistical methodologies to interpret them; the role of gene-environment interplay; and importantly, the potential role of genetic variation in suggesting new alternatives for treatment of addictions.
References
-
- American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders4th edn, Revised edn.American Psychiatric Association: Washington, DC; 1994
-
- Centers for Disease Control (CDC) Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States. MMWR. 2002;51:300–303. - PubMed
-
- Centers for Disease Control (CDC) Alcohol-Attributable Deaths and Years of Potential Life Lost—United States, 2001. MMWR. 2004;53:870. - PubMed
-
- Petry NM. Gambling and substance use disorders: current status and future directions. Am J Addict. 2007;16:1–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DA25886/DA/NIDA NIH HHS/United States
- R00DA023549/DA/NIDA NIH HHS/United States
- R01 DA030976/DA/NIDA NIH HHS/United States
- P50 AA011998/AA/NIAAA NIH HHS/United States
- R01 DA023668/DA/NIDA NIH HHS/United States
- R01 AA013326/AA/NIAAA NIH HHS/United States
- AA013326/AA/NIAAA NIH HHS/United States
- AA17688/AA/NIAAA NIH HHS/United States
- R01 AA017915/AA/NIAAA NIH HHS/United States
- DA17305/DA/NIDA NIH HHS/United States
- R01 DA018660/DA/NIDA NIH HHS/United States
- DA23668/DA/NIDA NIH HHS/United States
- DA030976/DA/NIDA NIH HHS/United States
- DA027046/DA/NIDA NIH HHS/United States
- DA18660/DA/NIDA NIH HHS/United States
- R01 AA014041/AA/NIAAA NIH HHS/United States
- K05 AA017688/AA/NIAAA NIH HHS/United States
- AA11998/AA/NIAAA NIH HHS/United States
- R03 DA025886/DA/NIDA NIH HHS/United States
- AA014041/AA/NIAAA NIH HHS/United States
- R00 DA023549/DA/NIDA NIH HHS/United States
- R01 DA017305/DA/NIDA NIH HHS/United States
- K01 DA027046/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
